°íȯ¼ø¼öÁ¤»óÇÇÁ¾ÀÇ ¹æ»ç¼±Ä¡·á
Radiotherapy Results of Testicular Pure Seminoma
±è¼ö°ï, Á¶°üÈ£, Ȳ¹Ì¼ö, ±è±Í¾ð, ¹ÚâÀ±,
¼Ò¼Ó »ó¼¼Á¤º¸
±è¼ö°ï ( )
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ¹æ»ç¼±°úÇб³½Ç
Á¶°üÈ£ ( )
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ¹æ»ç¼±°úÇб³½Ç
Ȳ¹Ì¼ö ( )
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ¹æ»ç¼±°úÇб³½Ç
±è±Í¾ð ( )
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ¹æ»ç¼±°úÇб³½Ç
¹ÚâÀ± ( )
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ¹æ»ç¼±°úÇб³½Ç
KMID : 0360319860180010041
Abstract
Between 1971 and 1983, 26 patients with testicular pure seminoma treated at the Yonsei Cancer Center with radiotherapy are analyzed.
The stage distribution was: stage ¥° 46%(12/26), stage ¥± 42(11/26), and stage ¥² 12% (3/26). Tumor histological subtypes were typical seminoma in 8 ]Patients, anaplastic seminoma in 4 patients, and unknown subtypes in 14 patients.
Three-year actuarial disease free survival rate was: overall 76%, stage ¥° 91%, stage ¥± 80%, stage ¥² 0%.
Treatment failure were analyzed to determine their apparent causes and the implication of such failures to the future management of the testicular pure seminoma.
Å°¿öµå
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸